带有 FAPI 的 PET/CT:肿瘤学中的程序和证据审查

IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Revista Espanola De Medicina Nuclear E Imagen Molecular Pub Date : 2024-03-01 DOI:10.1016/j.remn.2023.11.006
A.P. Caresia Aróztegui , J. Jo Rosales , M. Rodríguez Fraile , A. Arçay Öztürk , Carlos Artigas , en nombre del Grupo Oncología de la SEMNIM
{"title":"带有 FAPI 的 PET/CT:肿瘤学中的程序和证据审查","authors":"A.P. Caresia Aróztegui ,&nbsp;J. Jo Rosales ,&nbsp;M. Rodríguez Fraile ,&nbsp;A. Arçay Öztürk ,&nbsp;Carlos Artigas ,&nbsp;en nombre del Grupo Oncología de la SEMNIM","doi":"10.1016/j.remn.2023.11.006","DOIUrl":null,"url":null,"abstract":"<div><p>Neoplasms are composed of malignant tumour cells, which are surrounded by other non-tumour cellular elements, what has been defined as the microenvironment or tumour stroma. Evidence on the importance of the tumour microenvironment has not stopped growing in recent years. It plays a central role for cell proliferation, tissue invasion, angiogenesis and cell migration.</p><p>The paradigm is the family of new FAPI radiopharmaceuticals that show us the density of the fibroblast activation protein (FAP) that is overexpressed in the cell membrane of activated cancer-associated fibroblasts (CAF), and its presence is related to poor prognosis.</p><p>The paradigm is the family of new FAPI radiopharmaceuticals, which represents the density of activated fibroblasts associated with cancer. This educational document includes the procedure for performing PET/CT FAPI, biodistribution and the main potentially clinical applications in oncology to date.</p></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"43 2","pages":"Pages 130-140"},"PeriodicalIF":1.6000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PET/TC con FAPI: procedimiento y revisión de la evidencia en oncología\",\"authors\":\"A.P. Caresia Aróztegui ,&nbsp;J. Jo Rosales ,&nbsp;M. Rodríguez Fraile ,&nbsp;A. Arçay Öztürk ,&nbsp;Carlos Artigas ,&nbsp;en nombre del Grupo Oncología de la SEMNIM\",\"doi\":\"10.1016/j.remn.2023.11.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Neoplasms are composed of malignant tumour cells, which are surrounded by other non-tumour cellular elements, what has been defined as the microenvironment or tumour stroma. Evidence on the importance of the tumour microenvironment has not stopped growing in recent years. It plays a central role for cell proliferation, tissue invasion, angiogenesis and cell migration.</p><p>The paradigm is the family of new FAPI radiopharmaceuticals that show us the density of the fibroblast activation protein (FAP) that is overexpressed in the cell membrane of activated cancer-associated fibroblasts (CAF), and its presence is related to poor prognosis.</p><p>The paradigm is the family of new FAPI radiopharmaceuticals, which represents the density of activated fibroblasts associated with cancer. This educational document includes the procedure for performing PET/CT FAPI, biodistribution and the main potentially clinical applications in oncology to date.</p></div>\",\"PeriodicalId\":48986,\"journal\":{\"name\":\"Revista Espanola De Medicina Nuclear E Imagen Molecular\",\"volume\":\"43 2\",\"pages\":\"Pages 130-140\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola De Medicina Nuclear E Imagen Molecular\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2253654X23001233\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Medicina Nuclear E Imagen Molecular","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2253654X23001233","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤由恶性肿瘤细胞组成,其周围有其他非肿瘤细胞成分,即所谓的微环境或肿瘤基质。近年来,有关肿瘤微环境重要性的证据不断增加。它在细胞增殖、组织侵袭、血管生成和细胞迁移方面发挥着核心作用。这种范例是新型 FAPI 放射性药物系列,它向我们展示了成纤维细胞活化蛋白(FAP)的密度,这种蛋白在活化的癌症相关成纤维细胞(CAF)的细胞膜上过度表达,它的存在与不良预后有关。本教学文件包括 PET/CT FAPI 的操作步骤、生物分布以及迄今为止在肿瘤学中的主要潜在临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PET/TC con FAPI: procedimiento y revisión de la evidencia en oncología

Neoplasms are composed of malignant tumour cells, which are surrounded by other non-tumour cellular elements, what has been defined as the microenvironment or tumour stroma. Evidence on the importance of the tumour microenvironment has not stopped growing in recent years. It plays a central role for cell proliferation, tissue invasion, angiogenesis and cell migration.

The paradigm is the family of new FAPI radiopharmaceuticals that show us the density of the fibroblast activation protein (FAP) that is overexpressed in the cell membrane of activated cancer-associated fibroblasts (CAF), and its presence is related to poor prognosis.

The paradigm is the family of new FAPI radiopharmaceuticals, which represents the density of activated fibroblasts associated with cancer. This educational document includes the procedure for performing PET/CT FAPI, biodistribution and the main potentially clinical applications in oncology to date.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
Revista Espanola De Medicina Nuclear E Imagen Molecular RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
1.10
自引率
16.70%
发文量
85
审稿时长
24 days
期刊介绍: The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles.
期刊最新文献
PET/RM cardiovascular con [18F]F-FDG en el diagnóstico de miocardiopatía aguda inflamatoria Radiosinoviortesis con [90Y] citrato de ytrio en la sinovitis refractaria de rodilla: experiencia de 2 hospitales de referencia Heterogeneidad del tumor primario en la PET/TC con [68Ga]Ga-PSMA previa al tratamiento para la predicción de la recurrencia bioquímica en el cáncer de próstata Asociación entre las imágenes SPECT/CT con 99mTc-PSMA y los niveles de antígeno prostático específico (PSA) y fosfatasa alcalina (ALP) después de la terapia endocrina en pacientes con cáncer de próstata y metástasis óseas Terapia de ablación con yodo radiactivo de baja dosis (1,11 GBq) para el cáncer de tiroides diferenciado en el oeste de Turquía
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1